A method classifying biologics for formulary decision makingMichael S Broder
Partnership Health Analytic Research, LLC, Los Angeles, California 90025, USA
Manag Care Interface 19:30-2. 2006
..A method is suggested and illustrated, utilizing the group of biologic agents commonly used to treat psoriasis (including, for illustrative purposes, alefacept, efalizumab, etanercept, and infliximab)...
Poor disease control among insured users of high-dose combination therapy for asthmaMichael S Broder
Partnership for Health Analytic Research, 280 S Beverly Drive, Beverly Hills, CA 90212, USA
Allergy Asthma Proc 31:60-7. 2010
..After adjusting for age, gender, and baseline characteristics, results were similar. Many patients continue to have poor asthma control despite being adherent to high-dose combination therapy or using additional controller medications...
- Care of asthma patients in relation to guidelines
Michael S Broder
Partnership for Health Analytic Research, LLC, Beverly Hills, California 90212, USA
Allergy Asthma Proc 31:452-60. 2010
..Bringing care in line with EPR3 guidelines will require significant changes from current practice but will improve quality by reducing use of oral corticosteroids and increasing use of inhaled steroids...
- Treatment patterns for women with new episodes of uterine myomas in an insured population in the US
Michael S Broder
Partnership for Health Analytic Research, LLC, Los Angeles, CA 90025 7017, USA
Curr Med Res Opin 22:95-100. 2006
..This study examines the treatment patterns of insured women with new episodes of uterine myomas...
- Cost effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in treatment-naïve human immunodeficiency virus-infected patients in the United States
Michael S Broder
Partnership for Health Analytic Research, Beverly Hills, CA, USA
J Med Econ 14:167-78. 2011
..To evaluate lifetime cost effectiveness of atazanavir-ritonavir (ATV + r) versus lopinavir-ritonavir (LPV/r), both with tenofovir-emtricitabine, in US HIV-infected patients initiating first-line antiretroviral therapy...
- Elective oophorectomy in the gynecological patient: when is it desirable?
William H Parker
UCLA School of Medicine, Los Angeles, California, USA
Curr Opin Obstet Gynecol 19:350-4. 2007
..Oophorectomy is electively performed in approximately 300,000 US women per year who are having hysterectomy for benign disease...
- Adherence and persistence with omalizumab and fluticasone/salmeterol within a managed care population
Michael S Broder
Partnership for Health Analytic Research, Beverly Hills, California, USA
Allergy Asthma Proc 30:148-57. 2009
..Our study suggests that injected medications may have advantages in asthma treatment. A comprehensive program to improve adherence should address not just administration route but also patient factors that prevent proper medication use...
- Ratio of controller to total asthma medications: determinants of the measure
Michael S Broder
Partnership for Health Analytic Research, Beverly Hills, CA, USA
Am J Manag Care 16:170-8. 2010
..To investigate differences in demographics, physician specialty, and medication use between patients who achieve high versus low ratios of controller to total asthma medications...
- Using administrative claims data to estimate virologic failure rates among human immunodeficiency virus-infected patients with antiretroviral regimen switches
Michael S Broder
Partnership for Health Analytic Research, Beverly Hills, California 90212, USA
Med Decis Making 32:118-31. 2012
..To develop and validate a claims signature model that estimates proportions of HIV-infected patients in administrative claims databases who switched combination antiretroviral therapy (cART) regimens because of virologic failure...
- Cost-effectiveness of 21-gene assay in node-positive, early-stage breast cancer
Burton F Vanderlaan
Partnership for Health Analytic Research, Beverly Hills, CA 90212, USA
Am J Manag Care 17:455-64. 2011
..To assess impact on health outcomes and healthcare expenditures of adopting a 21-gene assay for women with early-stage, minimally node-positive, estrogen receptor-positive (N (1-3)/ER) HER2-negative breast cancer...
- Concomitant asthma medication use by patients receiving omalizumab 2003-2008
Michael S Broder
Partnership for Health Analytic Research, Beverly Hills, CA, USA
J Asthma 48:1058-62. 2011
..To examine patterns of omalizumab use in the first 5 years of its availability...
- Clinical and economic impact of adhesiolysis during repeat cesarean delivery
Vanja Sikirica
Ethicon Inc, Somerville, NJ 08876 0151, USA
Acta Obstet Gynecol Scand 91:719-25. 2012
..To estimate adhesiolysis rates at cesarean delivery (CD) and to estimate costs and clinical implications of performing adhesiolysis at repeat CD...
- Ovarian conservation at the time of hysterectomy for benign disease
William H Parker
UCLA School of Medicine, Los Angeles, California, USA
Clin Obstet Gynecol 50:354-61. 2007
..Therefore, the decision to perform prophylactic oophorectomy should be approached with great caution for the majority of women who are at low risk of developing ovarian cancer...
- Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia
Michael S Broder
Bristol Myers Squibb Company, Plaisboro, NJ, USA
J Med Econ 15:105-11. 2012
..To examine the effect of antipsychotic medication half-life on the risk of psychiatric hospital admission and emergency department (ED) visits among adults with schizophrenia...
- Measures of surgical quality: what will patients know by 2005?
Michael S Broder
Partnership for Health Analytic Research, LLC, Beverly Hills, CA 90211, USA
J Eval Clin Pract 11:209-17. 2005
..If surgical patients are able to choose higher quality providers, overall surgical quality might increase...
- Improving treatment outcomes with a clinical pathway for hysterectomy and myomectomy
Michael S Broder
Department of Obstetrics and Gynecology, University of California, Los Angeles School of Medicine, Box 951740, Los Angeles, CA 90095 1740, USA
J Reprod Med 47:999-1003. 2002
..To determine if using a postoperative clinical pathway for women having hysterectomy or myomectomy would improve clinical care...
- Comparison of long-term outcomes of myomectomy and uterine artery embolization
Michael S Broder
Departments of Obstetrics and Gynecology and Radiology, UCLA School of Medicine, Los Angeles, California 900095 1740, USA
Obstet Gynecol 100:864-8. 2002
..To compare long-term outcomes of uterine artery embolization and abdominal myomectomy in patients with symptomatic uterine myomas...
